-Bloomberg
Keybanc Maintains Overweight on PROCEPT BioRobotics, Raises Price Target to $48
Keybanc analyst Matthew Mishan maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and raises the price target from $47 to $48.
Related Posts
If You Invested $1000 In Advance Auto Parts 20 Years Ago, Here’s How Much You Would Have Today
Advance Auto Parts (NYSE:AAP) has outperformed the market over the past 20 years by 6.53% on an annualized basis producing an average annual return of 13.74%. Currently, Advance Auto Parts has a market capitalization of $12.89 billion.
Most Oversold Stocks In Consumer Staples Sector: Herbalife, United Natural Foods And More
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. Here’s the latest list of major oversold players in this sector.
Herbalife Nutrition Ltd. (NYSE: HLF)
